“There is daily dysfunction in drug development”. One major obstacle in the discovery process is the failure of pre-clinical animal models to predict human physiology. Organs-On-Chips were designed to overcome this challenge, and the sky is the limit for this groundbreaking technology.Read More
We're in the process of planning another exciting event for you! Please sign up to receive the announcement of our next event.
Check out these post-event wrap up articles from our editorial team.
What is a wearable? That was the question posed by to our panelists at Biotech Connection Boston’s recent event, Big Data Gets Personal: Transforming Healthcare in the Age of Wearable Tech. While it seems like a simple question, wearable technology has different meanings to researchers, designers, consumers, healthcare providers, and insurance companies. Wearables have sparked new areas of research along with new ethical concerns and data privacy issues.Read More
The biotech industry is on the rise, driven by rapid breakthroughs in fields such as gene therapy, personalized medicine, and immunotherapy. However, despite this scientific explosion, venture capital investments have remained largely unchanged since 2007 and numerous studies and articles have focused on a perceived funding shortage. In order to gain a first-hand account of the current status of the biotech investment environment, Biotech Connection Boston brought together funding expertsRead More
“My lab sometimes takes on a fair number of things that sound like science fiction. Faster than light and time travel may not be the right choice, but bringing back some DNA diversity might actually be beneficial to agriculture and ecosystems. Now it’s not all about bringing back the perfect good old days, it’s about adapting our current ecosystem to the reality of change. To maintain the ecosystems that are most useful to humans, we need to be thoughtful about maintaining keystone species to help maintain those systems.”Read More
MA truly represents everything that went well in the biotech industry last year. BioPharma employment in MA has grown by 40% over the past decade, and more jobs are being created every day. When factoring in company density and strength, MA has almost twice the concentration of jobs as the next closest state in the U.S. This is best exemplified in East Cambridge/Kendall Square, where 120 companies are clustered in only three square miles.Read More